Yung Cheng Wu - Net Worth and Insider Trading
Yung Cheng Wu Net Worth
The estimated net worth of Yung Cheng Wu is at least $165,468 dollars as of 2025-04-30. Yung Cheng Wu is the Director of MDA Space Ltd and owns about 3,800 shares of MDA Space Ltd (TSX:MDA) stock worth over $101,650. Yung Cheng Wu is also the Director of Antibe Therapeutics Inc and owns about 216,333 shares of Antibe Therapeutics Inc (TSX:ATE) stock worth over $63,818. Details can be seen in Yung Cheng Wu's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Yung Cheng Wu has not made any transactions after 2024-11-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Yung Cheng Wu
Yung Cheng Wu Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Yung Cheng Wu owns 2 companies in total, including Antibe Therapeutics Inc (TSX:ATE) , and MDA Space Ltd (TSX:MDA) .
Click here to see the complete history of Yung Cheng Wu’s form 4 insider trades.
Insider Ownership Summary of Yung Cheng Wu
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:ATE | Antibe Therapeutics Inc | 2021-11-01 | Director |
| TSX:MDA | MDA Space Ltd | 2024-11-22 | Director |
Yung Cheng Wu Latest Holdings Summary
Yung Cheng Wu currently owns a total of 2 stocks. Among these stocks, Yung Cheng Wu owns 3,800 shares of MDA Space Ltd (TSX:MDA) as of November 22, 2024, with a value of $101,650 and a weighting of 61.43%. Yung Cheng Wu also owns 216,333 shares of Antibe Therapeutics Inc (TSX:ATE) as of November 1, 2021, with a value of $63,818 and a weighting of 38.57%.
Latest Holdings of Yung Cheng Wu
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:MDA | MDA Space Ltd | 2024-11-22 | 3,800 | 26.75 | 101,650 |
| TSX:ATE | Antibe Therapeutics Inc | 2021-11-01 | 216,333 | 0.30 | 63,818 |
Holding Weightings of Yung Cheng Wu
Yung Cheng Wu Form 4 Trading Tracker
According to the SEC Form 4 filings, Yung Cheng Wu has made a total of 2 transactions in MDA Space Ltd (TSX:MDA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in MDA Space Ltd is the acquisition of 3,800 shares on November 22, 2024, which cost Yung Cheng Wu around $108,262.
According to the SEC Form 4 filings, Yung Cheng Wu has made a total of 8 transactions in Antibe Therapeutics Inc (TSX:ATE) over the past 5 years, including 8 buys and 0 sells. The most-recent trade in Antibe Therapeutics Inc is the acquisition of 25,000 shares on November 1, 2021, which cost Yung Cheng Wu around $22,250.
Insider Trading History of Yung Cheng Wu
- 1
Yung Cheng Wu Trading Performance
GuruFocus tracks the stock performance after each of Yung Cheng Wu's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Yung Cheng Wu is -15.75%. GuruFocus also compares Yung Cheng Wu's trading performance to market benchmark return within the same time period. The performance of stocks bought by Yung Cheng Wu within 3 months outperforms 1 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Yung Cheng Wu's insider trading performs compared to the benchmark.
Performance of Yung Cheng Wu
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -23.25 | | | | | |
| Relative Return to S&P 500(%) | -21.59 | | | | | |
Yung Cheng Wu Ownership Network
Ownership Network List of Yung Cheng Wu
Ownership Network Relation of Yung Cheng Wu
Yung Cheng Wu Owned Company Details
What does Antibe Therapeutics Inc do?
Who are the key executives at Antibe Therapeutics Inc?
Yung Cheng Wu is the Director of Antibe Therapeutics Inc. Other key executives at Antibe Therapeutics Inc include Director & Director or Senior Officer of 10% Security Holder & Senior Officer John Lawrence Wallace , Senior Officer Joseph Stauffer , and Senior Officer Scott Wilson Curtis .
Antibe Therapeutics Inc (TSX:ATE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Antibe Therapeutics Inc (TSX:ATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antibe Therapeutics Inc (TSX:ATE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Antibe Therapeutics Inc (TSX:ATE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Antibe Therapeutics Inc Insider Transactions
Yung Cheng Wu Mailing Address
Above is the net worth, insider trading, and ownership report for Yung Cheng Wu. Currently GuruFocus does not have mailing address information for Yung Cheng Wu.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
